Universe Pharmaceuticals INC Current Income Tax Expense (Benefit)
Universe Pharmaceuticals INC (UPC) reported Current Income Tax Expense (Benefit) of $685.94 million for the 12-month period ending 2023-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Expense Statement › Income Tax
us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-01-29
| Period end | Current Income Tax Expense (Benefit) 12 month | Current Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2023-09-30 | $685.94M 20-F · filed 2026-01-29 | $685.94K 20-F · filed 2024-01-30 |
| 2022-09-30 | $1.36M 20-F · filed 2025-04-29 | |
| 2021-09-30 | $3.03M 20-F · filed 2024-01-30 | |
| 2020-09-30 | $2.55M 20-F · filed 2023-02-10 | |
| 2019-09-30 | $2.14M 20-F · filed 2022-01-31 |